Juan Carlos
Vallejo Llamas
Hospital Vall d'Hebron
Barcelona, EspañaPublications in collaboration with researchers from Hospital Vall d'Hebron (20)
2021
-
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
Bone Marrow Transplantation, Vol. 56, Núm. 6, pp. 1281-1290
-
Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)
European Journal of Haematology, Vol. 106, Núm. 6, pp. 842-850
2020
-
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model
Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 12, pp. 2237-2244
2019
-
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy
Hematology/ Oncology and Stem Cell Therapy, Vol. 12, Núm. 4, pp. 194-203
2018
-
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment
Hematological Oncology, Vol. 36, Núm. 5, pp. 765-772
-
Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: A long-term follow-up analysis from the Spanish GELTAMO registry
Bone Marrow Transplantation
2017
-
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure
Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 10, pp. 1631-1640
-
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in spain
ClinicoEconomics and Outcomes Research, Vol. 9, pp. 39-47
-
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma
Cancer Medicine, Vol. 6, Núm. 12, pp. 2766-2774
-
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367
2015
-
A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation
Clinical Microbiology and Infection
-
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis
Annals of Hematology, Vol. 94, Núm. 6, pp. 947-954
-
Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: A randomized controlled trial
Clinical Infectious Diseases, Vol. 60, Núm. 3, pp. 405-414
2013
-
Tratamiento de las infecciones fúngicas invasoras en pacientes hematológicos de alto riesgo: ¿Qué hemos aprendido en los pasados 10 años?
Revista Espanola de Quimioterapia, Vol. 26, Núm. 4, pp. 378-386
2012
-
Infección fúngica invasora en los pacientes hematológicos
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 9, pp. 572-579
2011
-
Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Clinical Microbiology and Infection, Vol. 17, Núm. SUPPL. 2, pp. 1-24
2010
-
Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Núm. 3
2008
-
Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 58-71